samedan logo
 
 
publications
site nav  
 
 
 
 
 
 
 
air transport logo
Air Transport Publications
spacer
home > pmps > summer 2002 > developing custom adhesive systems for transdermal drug delivery products
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Developing Custom Adhesive Systems for Transdermal Drug Delivery Products
Pharmaceutical companies in search of unique pressure-sensitive adhesive systems for their transdermal drug delivery (TDD) products are turning to specialty adhesives manufacturers to carry out research and development, testing, materials qualification, manufacturing, quality and other product development tasks. Trends suggest that adhesives manufacturers are forming partnerships with pharmaceutical companies as part of the product development process that ultimately includes manufacturing adhesive products to the relevant pharmaceutical current Good Manufacturing Practices (cGMPs). This article also discusses the technological advances that are occurring in terms of types of transdermal patch, adhesive properties and specialised components in transdermal drug delivery systems (TDDS).

Transdermal Drug Delivery Systems

The use of TDDS continues to gain market acceptance as a selected method of drug administration. The success of products that deliver materials such as nicotine for smoking cessation, nitroglycerin for angina, oestradiol and testosterone for hormone replacement therapy, and oestrogen and progesterone for birth control has ensured that the TDDS market is a strong industry segment with many more drug actives being formulated for transdermal delivery methods.


Read full article >>
Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.
spacer
By Melinda Hopp, Director of Marketing at Adhesives Research, Inc. Melinda Hopp has served as Director of Marketing at Adhesives Research, Inc. for the past six years. She previously worked for Southern New England Telephone as Director of Business Development; Duracell, Inc. (a division of Gillette Company) as Director of Market Development; and Novo Laboratories USA (a former division of NovoNordisk, Denmark) as Director of Market Research.
She started her career as a Research Chemist with Lehn & Fink Products (then a division of Sterling Drug). She has a BA in Biology/Chemistry, an MA in Science and an MBA from Fairleigh Dickinson University in New Jersey, US.

spacer
Melinda Hopp
spacer
spacer
Print this page
Send to a friend
Privacy statement

Industry Events

EMBALLAGE 2008. World Packaging Exhibition

16-21 November 2008, Paris-Nord Villepinte - France

“Business, Innovation, Outlook” are the watchwords for the 38th World Packaging Exhibition which opens in Paris from 17 to 21 November 2008. Fifteen months before the key packaging event of the end of 2008, EMBALLAGE displays its differences to offer you a new edition that is even more representative, international and rich in new features.
More info >>

 
News and Press Releases

Aegate Proves Authenticating Drugs at the Point of Dispensing Protects Consumers

 
More info >>

 
©2000-2007 Samedan Ltd.
About Us | Register | Login | Site Map | Terms and Conditions | Contact Us |
Add to favourites

Print this page
Send to a friend
Privacy statement